Carbapenem-resistant Acinetobacter baumannii (CRAB) Recovered from Burn Patients
Open Access
- 17 August 2016
- journal article
- Published by Frontiers Media SA in Journal of Pharmacy & Pharmaceutical Sciences
- Vol. 19 (3) , 339-348
Abstract
Purpose. Emergence of carbapenem-resistant Acinetobacter baumannii (CRAB) and their prolonged presence in burn units increases the risk of acquisition of CRAB. Methods. From November 2012 to September 2013, 1474 burn patients were screened for CRAB isolates through testing susceptibility to imipenem and its comparators meropenem, and doripenem. Furthermore, the in vitro activity of other antibiotics against CRAB was investigated. Results. Three patients were infected with carbapenem-susceptible A. baumannii (CSAB) and 168 were infected with CRAB. Approximately one-fifth (n=32) of CRAB isolates were obtained from patients hospitalized in Burn Intensive Care Unit (BICU). Most of CRABs were isolated from wound. The mean length of stay (LOS) in hospital prior to A. baumannii isolation was significantly higher for CRAB compared to CSAB cases (P=0.04). Amongst the independent variables, percentage of total burn surface area (TBSA) significantly increased the mortality rate using multivariate logistic regression (P=0.001, OR= 16.5; 95% CI: 4.72-57.7). The majority of tested isolates were resistant to imipenem (94.8%), and to its comparators, doripenem (97.7%), and meropenem (97.7%). The susceptibility of CRAB isolates was less than 10% to all tested antibiotics except for colistin (100%), doxycycline (61.9%), gentamicin (18.5%), and tigecycline (11.9%). Conclusion. Resistance to carbapenem reduces the number of effective antibiotics. The coordinated and intensive efforts of healthcare personnel are required to meet the challenge of dissemination of CRAB.Keywords
This publication has 26 references indexed in Scilit:
- Study of the carbapenem resistance mechanisms in clinical isolates of Acinetobacter baumannii: Comparison of burn and non-burn strainsBurns, 2013
- Antimicrobial resistance patterns and their encoding genes among Acinetobacter baumannii strains isolated from burned patientsBurns, 2012
- Mutant prevention concentration of colistin alone and in combination with levofloxacin or tobramycin against multidrug-resistant Acinetobacter baumanniiInternational Journal of Antimicrobial Agents, 2012
- Comprehensive assessment of tigecycline activity tested against a worldwide collection of Acinetobacter spp. (2005–2009)Diagnostic Microbiology and Infectious Disease, 2010
- Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICUInternational Journal of Antimicrobial Agents, 2006
- Impact of Acinetobacter Infection on the Mortality of Burn PatientsJournal of the American College of Surgeons, 2006
- Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteriaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2006
- Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literatureJournal of Hospital Infection, 2006
- Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolatesDiagnostic Microbiology and Infectious Disease, 2005
- Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactamThe Lancet, 1994